EDA-Based Adaptive Support in VR ALS Training
Effects of Electrodermal Activity-Based Adaptive Support Systems on Performance in VR-Based Advanced Life Support Training: A Randomized Controlled Study
1 other identifier
interventional
72
0 countries
N/A
Brief Summary
This randomized controlled study aims to investigate the effects of an electrodermal activity (EDA)-based adaptive support system on performance during virtual reality (VR)-based advanced life support (ALS) training. Participants' stress levels will be continuously monitored through EDA during the simulation. When stress exceeds a predefined threshold, the adaptive system will automatically activate a support mode that provides additional guidance and time. The performance outcomes of participants receiving adaptive support will be compared with those receiving standard VR training. The study will also examine the role of presence, anxiety, social anxiety, and personality traits in the relationship between stress and performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2026
CompletedFirst Posted
Study publicly available on registry
June 16, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
CompletedJuly 2, 2026
June 1, 2026
Same day
June 11, 2026
July 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Advanced Life Support Performance Score
Participants' performance during the post-training VR-based advanced life support examination will be automatically evaluated by the simulation system. The score will reflect the accuracy and completeness of advanced life support procedures performed without guidance. Scores will range from 0 to 100 with higher scores indicating better success.
Up to 4 weeks
Secondary Outcomes (6)
Electrodermal Activity (EDA) Level
Up to 4 weeks
Presence Score
Up to 4 weeks
State Anxiety Score
Up to 4 weeks
Trait Anxiety Score
Up to 4 weeks
Social Anxiety Score
Up to 4 weeks
- +1 more secondary outcomes
Study Arms (2)
Adaptive Support
EXPERIMENTALParticipants in this arm will receive VR-based advanced life support training with an electrodermal activity (EDA)-based adaptive support system. During the simulation, participants' stress levels will be continuously monitored using EDA measurements. When stress exceeds a predefined threshold, the system will automatically activate a support mode that provides additional guidance, more frequent instructions, and extended response time.
Standard Training
EXPERIMENTALParticipants in this arm will receive standard VR-based advanced life support training without adaptive support. Although electrodermal activity (EDA) will be recorded throughout the simulation, the training flow will remain unchanged regardless of participants' stress levels, and no additional guidance or time adjustments will be provided.
Interventions
Participants receive VR-based advanced life support training with an electrodermal activity (EDA)-based adaptive support system that automatically provides additional guidance, more frequent instructions, and extended response time when stress levels exceed a predefined threshold.
Participants receive standard VR-based advanced life support training without adaptive support. Although electrodermal activity (EDA) is monitored during the simulation, the training flow remains unchanged regardless of stress levels.
Eligibility Criteria
You may qualify if:
- Being older than 18
You may not qualify if:
- prior completion of ALS training
- history of virtual reality (VR)-induced motion sickness
- medical conditions such as vertigo or the use of medications known to cause vertigo-like symptoms
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2026
First Posted
June 16, 2026
Study Start
July 1, 2026
Primary Completion
July 1, 2026
Study Completion
July 1, 2026
Last Updated
July 2, 2026
Record last verified: 2026-06